Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CB-103 With Abemaciclib or Lenvatinib in NOTCH Activated Adenoid Cystic Carcinoma (CALCulus)
NCT05774899Phase 2Recruiting
- Start
- Jun 2023
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of limantrafin in adenoid cystic carcinoma (ACC). Started Jun 2023; status: recruiting.
02
Drugs
limantrafin
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT05774899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05774899.